ImageneBio
IMA
ImageneBio (IMA) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$2.70
- EPS estimate
- −$0.33
- EPS surprise
- −716.67%
- Revenue surprise
- +0.00%
- Revenue
- −$500,000.00
- Revenue estimate
- $0.00
- Reported
- Jul 24, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Jul 24, 2025 | −$0.33 | −$2.70 | −716.67% | −$500,000.00 | SEC |
| Q1 2025 | May 8, 2025 | −$1.97 | −$2.04 | −3.47% | $0.00 | SEC |
| Q4 2024 | Mar 6, 2025 | −$2.99 | −$2.40 | +19.66% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$3.06 | −$2.52 | +17.61% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$4.16 | −$3.36 | +19.19% | $0.00 | SEC |
| Q1 2024 | May 13, 2024 | −$4.77 | −$3.96 | +17.02% | $0.00 | SEC |
| Q4 2023 | Mar 12, 2024 | −$4.99 | −$4.92 | +1.49% | $658,000.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$5.17 | −$4.80 | +7.12% | $1.2M | SEC |
| Q2 2023 | Aug 10, 2023 | −$5.69 | −$5.28 | +7.15% | $2.0M | SEC |
| Q1 2023 | May 15, 2023 | −$5.60 | −$4.68 | +16.41% | $5.3M | SEC |
| Q4 2022 | Mar 14, 2023 | −$1.75 | −$4.68 | −167.35% | $5.5M | SEC |
| Q3 2022 | Nov 7, 2022 | −$5.92 | −$5.76 | +2.72% | $6.4M | — |
| Q2 2022 | Aug 11, 2022 | −$5.86 | −$6.84 | −16.76% | $382,000.00 | — |
| Q1 2022 | May 12, 2022 | −$5.02 | −$5.64 | −12.41% | $3.4M | — |
| Q4 2021 | Mar 17, 2022 | −$6.15 | $0.84 | +113.66% | $20.2M | — |
| Q3 2021 | Nov 10, 2021 | −$5.04 | −$4.80 | +4.76% | $3.7M | — |
| Q2 2021 | Aug 12, 2021 | −$4.29 | −$4.20 | +2.10% | $3.5M | SEC |
| Q1 2021 | May 13, 2021 | −$10.46 | −$30.24 | −189.24% | $3.5M | — |
Quarterly revenue
Frequently asked questions
When did ImageneBio (IMA) last report earnings?
ImageneBio last reported on Jul 24, 2025, covering fiscal Q2 2025.
Did IMA beat earnings estimates?
No. ImageneBio reported EPS of −$2.70 for Q2 2025 against a −$0.33 estimate — a 716.67% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.